Cara Therapeutic Stock Investor Sentiment

CARA Stock  USD 0.31  0.01  3.33%   
About 58% of all Cara Therapeutic's investors are looking to take a long position. The analysis of overall sentiment of trading Cara Therapeutic stock suggests that some investors are interested at this time. The current market sentiment, together with Cara Therapeutic's historical and current headlines, can help investors time the market. In addition, many technical investors use Cara Therapeutic stock news signals to limit their universe of possible portfolio assets.
  

Cara Therapeutic Sentiment by Major News Outlets

Investor sentiment, mood or attitude towards Cara Therapeutic can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
over six months ago at news.google.com         
Will Cara Therapeutics Inc Lag the Rest of the Stocks in the Healthcare Sector - InvestorsObserver
Google News at Macroaxis
over six months ago at news.google.com         
Cara Therapeutics Inc has fallen -1.85 percent in a Week, Should You Sell - InvestorsObserver
Google News at Macroaxis
over six months ago at seekingalpha.com         
Cara to cut 50 percent of workforce, end CKD program to extend cash runway to 2026
seekingalpha News
over six months ago at globenewswire.com         
Cara Therapeutics Prioritizes Late-Stage Notalgia Paresthetica Program and Extends Cash Runway into ...
Macroaxis News: globenewswire.com
over six months ago at news.google.com         
Is it Time to Dump Cara Therapeutics Inc Stock After it Is Down 12.90 percent in a Week - InvestorsO...
Google News at Macroaxis
over six months ago at news.google.com         
Should Biotechnology Stock Cara Therapeutics Inc Be in Your Portfolio Tuesday - InvestorsObserver
Google News at Macroaxis
over six months ago at news.google.com         
Will Cara Therapeutics Inc Trail the Rest of the Stocks in the Healthcare Sector - InvestorsObserver
Google News at Macroaxis
over six months ago at news.google.com         
Cara Therapeutics Inc Stock What Does the Chart Say Tuesday - InvestorsObserver
Google News at Macroaxis
over six months ago at thelincolnianonline.com         
Cara Therapeutics, Inc. Stake Trimmed by Pinnacle Associates Ltd.
news
over six months ago at news.google.com         
Is Cara Therapeutics Inc Stock a Good Value Wednesday - InvestorsObserver
Google News at Macroaxis
over six months ago at news.google.com         
Cara Therapeutics Inc Stock Has Risen 17.91 percent This Week Buy, Hold, or Sell - InvestorsObserver
Google News at Macroaxis
over six months ago at thelincolnianonline.com         
Cara Therapeutics Stock Rating Upgraded by StockNews.com
news
over six months ago at news.google.com         
Is Cara Therapeutics Inc Stock About to Get Hot Thursday - InvestorsObserver
Google News at Macroaxis
over six months ago at thelincolnianonline.com         
Cara Therapeutics Given New 2.50 Price Target at HC Wainwright
news
over six months ago at thelincolnianonline.com         
Brokerages Set Cara Therapeutics, Inc. PT at 15.86
news
Far too much social signal, news, headlines, and media speculation about Cara Therapeutic that are available to investors today. That information is available publicly through Cara media outlets and privately through word of mouth or via Cara internal channels. However, regardless of the origin, that massive amount of Cara data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Cara Therapeutic news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Cara Therapeutic relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Cara Therapeutic's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Cara Therapeutic alpha.

Cara Therapeutic Performance against Dow Jones

 Price Growth (%)  
       Timeline  
1
Following more layoffs, Stamfords Cara Therapeutics considers strategic alternatives, including dissolving company - Hartford Business Journal
08/30/2024
2
Wall Street SWOT Cara Therapeutics stock navigates pivotal phase in drug development - Investing.com
09/27/2024
3
Disposition of 2483 shares by Scott Terrillion of Cara Therapeutic at 3.51 subject to Rule 16b-3
10/28/2024
4
Disposition of 3668 shares by Christopher Posner of Cara Therapeutic at 0.29 subject to Rule 16b-3
11/04/2024
5
Cara Therapeutics CEO Posner sells shares worth 1,063
11/06/2024
6
Cara Q3 Earnings Snapshot
11/15/2024

Complementary Tools for Cara Stock analysis

When running Cara Therapeutic's price analysis, check to measure Cara Therapeutic's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cara Therapeutic is operating at the current time. Most of Cara Therapeutic's value examination focuses on studying past and present price action to predict the probability of Cara Therapeutic's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cara Therapeutic's price. Additionally, you may evaluate how the addition of Cara Therapeutic to your portfolios can decrease your overall portfolio volatility.
Global Correlations
Find global opportunities by holding instruments from different markets
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets